Edition:
United Kingdom

Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

1.40USD
8 Dec 2017
Change (% chg)

$0.04 (+2.94%)
Prev Close
$1.36
Open
$1.35
Day's High
$1.41
Day's Low
$1.35
Volume
20,807
Avg. Vol
29,819
52-wk High
$5.69
52-wk Low
$1.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 18.90 -1.349
Jun '17 23.36 -2.003
Mar '17 19.15 -4.666
FY 2016 Dec '16 13.88 -1.686
Sep '16 7.00 1.302
Jun '16 7.79 -1.732
Mar '16 5.03 -1.535
FY 2015 Dec '15 4.93 -1.223
Sep '15 9.97 -0.859
Jun '15 5.19 -1.798
Mar '15 4.36 -1.391
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 25.00 25.00 25.00 15.30
Quarter Ending Mar-18 1 27.50 27.50 27.50 --
Year Ending Dec-17 2 85.85 87.00 84.70 69.49
Year Ending Dec-18 2 133.25 156.50 110.00 --
Earnings (per share)
Quarter Ending Dec-17 1 -2.06 -2.06 -2.06 --
Quarter Ending Mar-18 1 -2.17 -2.17 -2.17 --
Year Ending Dec-17 2 -8.60 -7.13 -10.08 -5.02
Year Ending Dec-18 2 -5.15 -3.54 -6.76 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta 2.39 0.85 0.88
Price to Sales (TTM) 0.50 100.67 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 48.46 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 199.78 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 128.58 75.03 5.38
Sales - 5 Yr. Growth Rate 50.27 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.63 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -31.87 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.36 1.68 2.18
Current Ratio (MRQ) 2.73 5.36 2.98
LT Debt to Equity (MRQ) -- 18.92 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 69.65 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -131.60 -- --
EBITD - 5 Yr. Avg -255.08 -261.11 15.24
Operating Margin (TTM) -103.57 -556.64 7.76
Operating Margin - 5 Yr. Avg. -246.13 -279.29 10.75
Pre-Tax Margin (TTM) -120.56 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -246.37 -279.02 11.17
Net Profit Margin (TTM) -120.77 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -247.63 -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 480,197 25,314,503 864,673,366
Net Income/Employee (TTM) -579,932 3,332,048 101,717,513
Receivable Turnover (TTM) 12.01 21.54 5.76
Inventory Turnover (TTM) 1.41 2.01 3.34
Asset Turnover (TTM) 0.24 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.59 -0.78 11.00
Return on Assets - 5 Yr. Avg. -29.98 -0.26 12.43
Return on Investment (TTM) -33.37 2.35 14.46
Return on Investment - 5 Yr. Avg. -35.15 2.98 16.28
Return on Equity (TTM) -- 2.95 16.05
Return on Equity - 5 Yr. Avg. -118.72 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 37.82 114.24 50.27
EPS (TTM) % 67.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Orexigen Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.82 -13.90 17 54
13 Week -30.41 -33.79 12 61
26 Week -22.26 -28.17 30 69
52 Week -35.62 -45.44 27 46
YTD 18.39 3.97 60 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.54%
# of Holders: 59
Total Shares Held: 7,027,335
3 Mo. Net Change: -379,965
# New Positions: 5
# Closed Positions: 13
# Increased Positions: 17
# Reduced Positions: 22
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.